Coagulation, Platelets & Antiplatelet Therapy (Neal S. Kleiman, MD) Saturday,, August 20, 2016
Cardiovascular Fellows' Bootcamp 2016 CARDIOLOGY FOUNDATION SESSION "Coagulation, Platelets & Antiplatelet Therapy" Neal S. Kleiman, MD Saturday, ...
Houston Methodist DeBakey CV Education
Dr K K Aggarwal - What should be the duration of dual antiplatelet therapy?
In this video, Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will talk about the duration of dual antiplatelet ...
Medtalks
Onyx ONE: aspirin vs. P2Y12 after 1-month dual antiplatelet therapy for high bleeding risk patients
Watch this video if you want: - To review the highlights of the Onyx ONE Month DAPT Program - To listen to commentary on the SAPT late breaker sub-analysis ...
PCR
Anti Platelet Drugs (Part 01)= Introduction and Classification (HINDI) By Solution Pharmacy
How to Download Notes in PDF from Solution Pharmacy Facebook Group Using Laptop https://youtu.be/cE5MAt0J6hs Using Mobile ...
Solution- Pharmacy
The Changing Face of Dual Anti-Platelet Therapy: Implications for the Internist
The anti-platelet therapy webcast reviews the implications of dual anti-platelet therapy for the Internist. Visit http://www.ccfcme.org/cardiopcpvideos to claim CME ...
ClevelandClinicCME
Current State of Antiplatelet Therapy
Cardiology Conference hosted by: L. Kristin Newby, MD presented by: Tracy Wang, MD, MHS.
Duke Clinical Research Institute
Guideline Directed Anti-Platelet Therapy in ACS / MI - Dr. Joseph Sweeny
CCC Symposium
Antiplatelet Therapy and Zotarolimus Stents
Dual Antiplatelet Therapy Duration and Clinical Outcomes Following Treatment with Zotarolimus-Eluting Stents. Habib Samady, MB, ChB, FACC David E.
American College of Cardiology
Shorten antiplatelet therapy after coronary stenting?
Dr. Cindy L. Grines gives a clinician's perspective on OPTIMIZE trial results, which found similar safety with either 3 months or 6 months of dual antiplatelet ...
MDedge: news and insights for busy physicians
Post-Stent Antiplatelet Therapy: Longer Wasn't Better
Dr. Gordon Tomaselli discusses the clinical implications of a study showing that up to 24 months of dual antiplatelet therapy after coronary stent implantation was ...
MDedge: news and insights for busy physicians
Coagulation, Platelets, and Antiplatelet Therapy (Neal Kleiman, MD)
SESSION 5 ▫ Cardiology Foundation Coagulation, Platelets, and Antiplatelet Therapy (Neal Kleiman, MD) CARDIOLOGY TRACK CARDIOVASCULAR ...
Houston Methodist DeBakey CV Education
Antiplatelet therapy in patients with prior CVA [ID 39216]
Video abstract of Review paper "Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and ...
Dove Medical Press
How long to give dual antiplatelet therapy (DAT) in acute MI? | Dr Viveka Kumar | Medtalks
In this video, Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket, will discuss the dual antiplatelet therapy in acute myocardial ...
Medtalks
Heart Minute | Dual Antiplatelet Therapy after Ischemic Stroke or TIA
A meta-analysis of randomized trials evaluating dual versus monotherapy for ischemic stroke or TIA.
American College of Cardiology
Medicine Grand Rounds: Antiplatelet and Anticoagulation Therapy After PCI 1/28/20
Speaker: Michael C. McDaniel, MD Associate Professor of Medicine Division of Cardiology Emory School of Medicine.
Emory Department of Medicine
Lumbar Puncture and Dual Antiplatelet Therapy
Dr. Ivan (Darin) Carabenciov, a fourth-year Resident in Neurology at Mayo Clinic in Rochester, MN, discusses his Brief Report appearing in the May 2018 issue ...
Mayo Proceedings
Risk and Benefit of Prolonged Dual Antiplatelet Therapy (DAPT trial) at AHA.14
Dr. Yogesh Reddy interviews Dr. Laura Mauri regarding use of prolonged dual antiplatelet therapy as discussed in the DAPT Trial at AHA.14.
FITsontheGO
A Look Into The Future of Antiplatelet Therapy
Sunil Rao Bob Harrington.
Duke Clinical Research Institute
DAPT and Triple Therapy: Updates on Latest Evidence for Patients with CAD Undergoing PCI
A Department of Medicine Grand Rounds presented by Roxana Mehran, MD, Professor of Medicine (Cardiology) and Population Health Science and Policy.
Icahn School of Medicine
Antiplatelet Therapy Post PCI - Roxana Mehran, MD
Presentation recorded at Cardiovascular Innovations 2017. CVI2017 was hosted by Cardiovascular Innovations Foundation at the Grand Hyatt Hotel Denver, ...
Cardiovascular Innovations
TAILOR-PCI and the role of genotype-guided antiplatelet therapy
Mayo Clinic cardiologist Naveen L. Pereira, M.D., and University of Toronto cardiologist Michael Farkhouh, M.D., MSc, discuss the TAILOR-PCI trial in this video ...
Mayo Clinic
Controversies in Antiplatelet Therapy for the Secondary Prevention of Cardiovascular Events
Watch this roundtable discussion if you want: - To understand more about the guidelines for antiplatelet secondary prevention of ACS/PC - To review available ...
PCR
ESC 2015: Dual antiplatelet therapy in unstable angina - Prof Gislasen
Professor Gunnar Gislasen, Gentofte University Hospital, Denmark, talks to Cardio Debate about his recent study that investigates the differences in dual ...
Cardio Debate
Dual antiplatelet therapy in everyday practice: EuroPCR 2015 Great Debate
Watch EuroPCR 2015 Great Debate panel members Andreas Baumbach, Tony Gershnick, Martine Gilard and Stephan James review the discussion that took ...
PCR
What is New in Antiplatelet Therapy? :: Deepak Bhatt, MD :: Part 1 of 2
Deepak L. Bhatt MD, MPH, FACC, FSCAI, FESC, FAHA Chief of Cardiology, VA Boston Healthcare System Director, Integrated Interventional Cardiovascular ...
NAThrombosisForum
Meta-Analysis: Insight into the Long-term Use of Dual Antiplatelet Therapy
CSWN talks with Zaher Fanari, MD, an interventional fellow in the Cardiology Division of the University of Kansas, about his meta-analysis of DAPT.
CSWNews
TRIGGER-PCI Shows the Challenge of Personalized Antiplatelet Therapy
TRIGGER-PCI evaluated the effectiveness of prasugrel versus clopidogrel in patients with high on-treatment platelet reactivity when taking clopidogrel after ...
CSWNews
Cardiology | Dual Anti Platelet Therapy After a Heart Attack
Dual Anti Platelet Therapy (DAPT) After Myocardial Infarction (MI) and Drug Eluting Stent (DES) Placement When you have a heart attack, or a myocardial ...
KittyKatzMD
DAPT: A Concise Summary.
Summary of the DAPT trial, which found that an additional 18 months of dual antiplatelet therapy after placement of a drug-eluting stent resulted in improved ...
NEJMvideo
Afib: Antithrombotic Therapy in Patients with AF and CAD
This video focuses on the algorithm for the management of antithrombotic therapy in patients with A.F. and concomitant C.A.D.. Patients with both A.F. and ...
Canadian Cardiovascular Society
Dual Antiplatelet Therapy for ACS (Discussion) | Deepak Bhatt, MD, MPH
Dual Antiplatelet Therapy for Acute Coronary Syndromes: 2013 Update (Discussion) Deepak L. Bhatt, MD, MPH NATF Thrombosis Summit 2013 September 28, ...
NAThrombosisForum
Optimizing Antiplatelet Therapy in Diabetes Mellitus | Dominick J. Angiolillo
Optimizing Antiplatelet Therapy in Diabetes Mellitus Dominick J. Angiolillo University of Florida, College of Medicine-Jacksonville, California, USA.
האיגוד הקרדיולוגי בישראל
Effect of dual antiplatelet therapy versus anticoagulation 6
Resolution of reduced leaflet motion following 3 months of anticoagulation with rivaroxaban after index CT; as also shown in figures 2K–L of the associated ...
The Lancet
Dual antiplatelet therapy: How long is long enough?
http://www.theheart.org/editorial-program/1231731.do A small trial testing the appropriate duration of dual antiplatelet therapy suggests that some patients can ...
theheartorg
(Board Review) - Antiplatelet Therapy - Dr. Sweeny
CCC Symposium
Antiplatelet Therapy For The Primary Prevention Of CVD’s In Diabetic Patients.
Dr. Kausik Ray is a professor of public health and an esteemed cardiology consultant at the Imperial College, NHS Trust. In this exclusive commentary, Dr. Ray ...
Docplexus
Effect of dual antiplatelet therapy versus anticoagulation 1
Reduced leaflet motion at baseline in a patient receiving dual antiplatelet therapy after transcatheter aortic valve replacement; as also shown in figures 2A–B of ...
The Lancet
Effect of dual antiplatelet therapy versus anticoagulation 8
Resolution of reduced leaflet motion following 3 months of anticoagulation with apixaban after index CT; as also shown in figures 2O–P of the associated Article.
The Lancet
What Is the Right Antiplatelet Therapy Regimen for CLI? - Matthew Bunte, MD
Presentation recorded at Cardiovascular Innovations 2017. CVI2017 was hosted by Cardiovascular Innovations Foundation at the Grand Hyatt Hotel Denver, ...
Cardiovascular Innovations
Effect of dual antiplatelet therapy versus anticoagulation 7
Reduced leaflet motion after transcatheter aortic valve replacement; as also shown in figures 2M–N of the associated Article. Article published: March 19, 2017 ...
The Lancet
Effect of dual antiplatelet therapy versus anticoagulation 2
Worsening reduced leaflet motion with follow-up CT in a patient receiving dual antiplatelet therapy after transcatheter aortic valve replacement; as also shown in ...
The Lancet
Long-term Dual Antiplatelet Therapy After PCI
At Napa 2019, Dr. Prashant Kaul with Piedmont Heart discusses dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with a drug-eluting ...
Piedmont Heart Institute
